Company Filing History:
2 out of 69 
1 out of 30 
1 out of 3,440 
Years Active: 2021-2024
Title: Wei Zhu: Innovator in T Cell Receptor Development
Introduction
Wei Zhu is a notable inventor based in Augusta, GA, who has made significant contributions to the field of immunology. He holds 2 patents that focus on the development of T cell receptors specifically designed to recognize human alpha fetoprotein (hAFP). His work has implications for therapeutic applications in cancer treatment and other diseases.
Latest Patents
Wei Zhu's latest patents include:
1. **Human alpha fetoprotein-specific T cell receptors and uses thereof** - This patent describes T cell receptors that specifically recognize hAFP and methods of their use.
2. **Human alpha fetoprotein-specific murine T cell receptors and uses thereof** - This patent also focuses on T cell receptors that specifically recognize hAFP and outlines methods for their application.
Career Highlights
Throughout his career, Wei Zhu has worked with esteemed organizations such as the Augusta University Research Institute, Inc. and the National Institutes of Health (NIH). His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Wei Zhu has collaborated with notable colleagues, including Yukai He and Esteban Celis. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Wei Zhu's work in developing T cell receptors that target human alpha fetoprotein showcases his commitment to advancing medical science. His patents and collaborations reflect his significant impact in the field of immunology.